Clinical Trial Update: Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant. [Phase 2]

View source ↗

Summary

Phase II feasibility study evaluating focal therapy using permanent iodine-125 localized implants for good-prognosis localized prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Iodine-125 seed brachytherapy implant (iodine-125 seed brachytherapy implant)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Localized Prostate Cancer | Phase 2 | Status: COMPLETED